EU Commission authorises German company to use chromium trioxide in certain medical devices until 2029

Reference of the decision - C(2020)1655

Substance name - chromium trioxide EC No 215-607-8; CAS No 1333-82-0

Holder of the authorisation: HAPOC GmbH & Co KG, S.A, In der Neuen Welt 8, 87700, Memmingen, Germany

Authorisation number - REACH/19/41/0

Authorised uses - Use in solid form and in aqueous solution of any composition to modify the properties of surfaces made of brass or bronze for medical engineering products, exclusively for the final preparation of such surfaces and the transparent plating of an interior housing part of an anaesthesia evaporator for further incorporation into anaesthetic machines for hospitals and clinics

Date of expiry of review period - 21 September 2029

Reasons for the decision - In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socioeconomic benefits outweigh the risk to human health arising from the use of the substance and there are no suitable alternative substances or technologies.: In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socioeconomic benefits outweigh the risk to human health arising from the use of the substance and there are no suitable alternative substances or technologies.

SOURCE: eur-lex.europa.eu